Exhibit 107
Calculation of Filing Fee Tables
Form S-1
(Form Type)
Propanc Biopharma, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Share | Maximum Aggregate Offering Price (1) | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial effective date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||||||||||||||||||||||
| Newly Registered Securities | ||||||||||||||||||||||||||||||||||||||||||||
| Fees to be paid | Equity | Units consisting of shares of Common Stock, par value $0.001 per shares (“Common Shares”, Tradeable Warrants to purchase Common Shares, and Non-tradeable Warrants to purchase Common Shares (1) | 457 | (o) | 1,725,000 | $ | 6.00 | $ | 10,350,000 | $153.10 per $1,000,000 | $ | 1,584.59 | — | — | — | — | ||||||||||||||||||||||||||||
| Equity | Common Stock, par value $0.001 per share, included as part of the Units (1) (2) | 457 | (o) | — | — | Included with above Units | — | — | — | — | — | |||||||||||||||||||||||||||||||||
| Equity | Warrants to purchase Common Shares, included as part of the Units (1) | 457(o) and 457(g) | — | — | Included with above Units | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
| Equity | Common Shares issuable upon exercise of the Warrants included as part of the Units (1) (2) | 457 | (o) | 1,725,000 | $ | 6.90 | $ | 11,902,500 | $153.10 per $1,000,000 | $ | 1,822.27 | — | — | — | — | |||||||||||||||||||||||||||||
| Equity | Common Stock, par value $0.001 per share, to be registered for the Selling Stockholders (6) | 457 | (c) | 3,091,500 | $ | 5.25 | $ | 16,230,575 | $153.10 per $1,000,000 | $ | 2,484.87 | |||||||||||||||||||||||||||||||||
| Equity | Representative’s Warrants (3) | 457 | (g) | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||
| Equity | Common stock, par value $0.001 per share (Representative’s Warrant Shares) (2) (4) | 457 | (g) | 45,000 | $ | 6.00 | $ | 270,000 | $153.10 per $1,000,000 | $ | 41.34 | — | — | — | — | |||||||||||||||||||||||||||||
| Fees previously paid | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||
| Carry Forward Securities | ||||||||||||||||||||||||||||||||||||||||||||
| Carry Forward Securities | ||||||||||||||||||||||||||||||||||||||||||||
| Total Offering Amounts | $ | 5,933.07 | ||||||||||||||||||||||||||||||||||||||||||
| Total Fees Previously Paid | $ | 918.60 | ||||||||||||||||||||||||||||||||||||||||||
| Total Fee Offsets | $ | 0 | ||||||||||||||||||||||||||||||||||||||||||
| Net Fee Due | $ | 5,014.47 | ||||||||||||||||||||||||||||||||||||||||||
| (1) | Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”). Includes units (and shares and warrants) to be sold upon exercise of the underwriters’ option to purchase additional units. |
| (2) | Pursuant to Rule 416 of the Securities Act, the shares of common stock registered hereby also includes an indeterminable number of additional shares of common stock as may from time to time become issuable by reason of stock splits, stock dividends, recapitalizations or other similar transactions. |
| (3) | No fee required pursuant to Rule 457(g) under the Securities Act. |
| (4) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act. The Representative’s Warrants are exercisable for a number of shares equal to 3% of the aggregate number of shares of common stock offered hereby at the same rate as the Warrants offered to investors, at a per share exercise price equal to 100% of the public offering price per share. As estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act, the proposed maximum aggregate offering price of the Representative’s Warrants (including the over-allotment) is $270,000, which is equal to 3% of the common shares issued in the offering at an exercise price of 100% of the proposed maximum offering price. |
| (5) | The registration statement also covers the resale under a separate resale prospectus (the “Resale Prospectus”) by selling stockholders of the registrant of up to 3,091,500 shares of common stock previously issued to the selling stockholders as named in the Resale Prospectus. Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based on the average of the high and low prices reported on OTCMarkets.com on March 28, 2025. |